Lympho Bob
A blog about Cancer in general, and Follicular Lymphoma in particular
Tuesday, June 21, 2022
ASCO: Bispecific + R-Squared
›
Before I get to more ASCO news, a quick announcement: I was nominated again this year for a WEGO Health Award. Except there have been a lot ...
Thursday, June 16, 2022
The Biggest News at ASCO (It's Not About Lymphoma)
›
More from the ASCO conference: Based on how many people outside the cancer community are talking about it, the biggest news at ASCO is this ...
1 comment:
Saturday, June 11, 2022
ASCO: Mosunetuzumab (EC Approval + ASCO)
›
I still have a few ASCO abstracts that I want to write about, but I'm skipping ahead to this one: " CELESTIMO: A phase III trial e...
Monday, June 6, 2022
ASCO: Unmet Information Needs
›
More comments on presentations at this year's ASCO meeting. Yesterday (June 5) was National Cancer Survivors Day . A "survivor,...
4 comments:
‹
›
Home
View web version